4//SEC Filing
Chiswell David 4
Accession 0001209191-22-039592
CIK 0001322505other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 4:00 PM ET
Size
5.5 KB
Accession
0001209191-22-039592
Insider Transaction Report
Form 4
Chiswell David
DirectorOther
Transactions
- Award
Stock Option (right to buy)
2022-06-24+8,000→ 8,000 totalExercise: $19.47Exp: 2032-06-23→ Common Stock (8,000 underlying)
Footnotes (1)
- [F1]This option will vest and become exercisable in full on the earlier of (i) June 24, 2023 or (ii) the day prior to the issuer's 2023 annual meeting of stockholders, subject to the director's continued service on the issuer's board of directors on the vesting date.
Documents
Issuer
ALBIREO PHARMA, INC.
CIK 0001322505
Entity typeother
Related Parties
1- filerCIK 0001687093
Filing Metadata
- Form type
- 4
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 4:00 PM ET
- Size
- 5.5 KB